- Image Analysis:
Catalogue number: CA200719
Product: β2 antagonist [(±)-alprenolol]
Selectivity: β1: 7.50 | β2: 8.91 | β3: 7.09
|Pharmacophore||(±)-Alprenolol-derivative||Catalogue Number||Pack Size||Price|
|Molecular Weight||884||CA200719-TK0*||0.05 mg||£137.50*|
|Excitation||633 nm||CA200719-050||0.5 mg||£1200|
|Emission||650 nm||CA200719-100||1.0 mg||£2150|
For imaging at β1 / β2 / β3 adrenoceptors use solutions up to 100 nM.
The CA200719 ligand was shown to antagonize the activity of the non-selective β agonist, isoprenaline, in three separate recombinant CHO cell lines expressing either the human β1, β2 or β3 receptor and a cyclic AMP-responsive secreted placental alkaline phosphatase (SPAP) reporter gene.
To determine the apparent KD for CA200719 at β1, β2 and β3 receptors, cells were treated with varying concentrations of isoprenaline alone, or in the presence of 1µM CA200719, and the cyclic AMP-induced expression of SPAP measured.
The apparent KD was calculated from the rightward shift of the agonist response curve in the presence of CA200719, compared to the response curve for the agonist alone, for β1, β2 and β3 receptor expressing cell lines.